Genprex, Inc. Balance Sheet
GNPX|6 years of annual SEC 10-K data (FY2017-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Genprex, Inc. had $4M in total assets and $7M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.6M | $6.7M | - | - | - | $1.6M |
| Accounts Receivable | - | $0 | $34.9K | $0 | - | - |
| Current Assets | $2.1M | $7.5M | $21.5M | $39.1M | $8.8M | $193.6K |
| PP&E (Net) | $0 | $7.9K | $23.0K | $48.6K | $24.4K | $7.8K |
| Total Assets | $4.1M | $10.7M | $25.1M | $42.9M | $9.3M | $1.3M |
| Current Liabilities | $2.5M | $3.3M | $2.8M | $1.6M | $387.8K | $831.0K |
| Shareholders' Equity | $7.4M | $22.3M | $41.3M | $30.9M | $428.6K | $1.6M |